Naseem Salahuddin
Overview
Explore the profile of Naseem Salahuddin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guglielmetti L, Khan U, Velasquez G, Gouillou M, Abubakirov A, Baudin E, et al.
N Engl J Med
. 2025 Jan;
392(5):468-482.
PMID: 39879593
Background: For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now permit randomized,...
2.
Kho S, Seung K, Huerga H, Bastard M, Khan P, Mitnick C, et al.
Nat Commun
. 2024 May;
15(1):3927.
PMID: 38724531
Sputum culture reversion after conversion is an indicator of tuberculosis (TB) treatment failure. We analyze data from the endTB multi-country prospective observational cohort (NCT03259269) to estimate the frequency (primary endpoint)...
3.
Rodriguez C, Lodi S, Horsburgh C, Mitnick C, Bastard M, Huerga H, et al.
PLOS Glob Public Health
. 2023 Apr;
3(4):e0000818.
PMID: 37115740
Clarity about the role of delamanid in longer regimens for multidrug-resistant TB is needed after discordant Phase IIb and Phase III randomized controlled trial results. The Phase IIb trial found...
4.
Hussain H, Jaswal M, Farooq S, Safdar N, Madhani F, Noorani S, et al.
Clin Infect Dis
. 2023 Apr;
77(4):638-644.
PMID: 37083926
Background: Scaling up a shorter preventive regimen such as weekly isoniazid and rifapentine (3HP) for 3 months is a priority for tuberculosis (TB) preventive treatment (TPT). However, there are limited...
5.
Malik A, Khan U, Khan P, Anwar A, Salahuddin N, Khowaja S, et al.
Trop Med Infect Dis
. 2022 Dec;
7(12).
PMID: 36548673
Background: Significant data gaps exist for children and adolescents with drug-resistant (DR) TB, particularly from high TB incidence settings. This report provides a descriptive analysis of programmatic outcomes among children...
6.
Thumbi S, Blumberg L, le Roux K, Salahuddin N, Abela B
Lancet
. 2022 Dec;
400(10369):2261-2264.
PMID: 36528379
No abstract available.
7.
Shaikh Q, Sarfaraz S, Rahim A, Hussain A, Behram S, Kazi A, et al.
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36358210
Antimicrobial stewardship is a systematic approach for promoting and monitoring responsible antimicrobial use globally. We conducted a prospective point prevalence survey of antimicrobial utilization among hospitalized adult patients during September...
8.
Khan U, Lotia-Farrukh I, Akhtar A, Khowaja S, Khan S, Madhani F, et al.
Health Policy Plan
. 2022 May;
37(8):979-989.
PMID: 35527232
Decentralized, person-centred models of care delivery for drug-resistant tuberculosis (DR-TB) continue to be under-resourced in high-burden TB countries. The implementation of such models-made increasingly urgent by the COVID-19 pandemic-are key...
9.
Huerga H, Khan U, Bastard M, Mitnick C, Lachenal N, Khan P, et al.
Clin Infect Dis
. 2022 Mar;
75(8):1307-1314.
PMID: 35243494
Background: Concomitant use of bedaquiline (Bdq) and delamanid (Dlm) for multi-drug/rifampicin resistant tuberculosis (MDR/RR-TB) has raised concerns about a potentially poor risk-benefit ratio. Yet this combination is an important alternative...
10.
Salahuddin N, Ansari N, Gohar M
Bull World Health Organ
. 2021 Jul;
99(7):506-513.
PMID: 34248223
Objective: To assess the cost and effectiveness of the two-site, 1-week, intradermal rabies post-exposure prophylaxis regimen recommended by the World Health Organization (WHO) in 2018. Methods: We compared the number...